Systemic haemodynamics in three infants with severe cardiac failure secondary to vein of Galen malformation (VGAM) were studied using two-dimensional and Doppler echocardiography. In all cases, ventricular outputs were over two times normal and superior vena caval flows up to 10 times normal reflecting high flow through the low-resistance fistula. Severe pulmonary hypertension, right heart dilatation and retrograde flow in the descending aorta were uniformly present. Systemic blood flow below the head and neck was reduced resulting in metabolic acidosis at presentation. Two infants had patent arterial ducts, in which flow was entirely right to left and on entering the aorta passed predominantly retrogradely towards the VGAM. These findings provide a basis for understanding the pathophysiology of cardiac failure in VGAM and support treatment with pulmonary and systemic vasodilating agents.
Introduction
Vein of Galen malformation (VGAM) is a congenital arterio-venous fistula in the brain. Cardiovascular and neurological complications may present from the newborn period to late childhood, and are associated with high morbidity and mortality. 1 In newborn infants, VGAM can present with high output cardiac failure due to high blood flow through the low-resistance fistula. Blood flow to the remainder of the body is reduced, and may result in ischaemic multiple organ failure and death without treatment. 2 Successful treatment in newborn infants involves initial cardiovascular stabilization together with endovascular embolization of feeding arteries and draining veins. 3 Echocardiography, including Doppler studies, have proven useful non-invasive means of studying the circulation in VGAM. 4 We have used these techniques to provide detailed haemodynamic analysis in three infants with VGAM presenting with cardiac failure in infancy, as a basis for understanding the pathophysiology of this condition and identifying strategies for treating cardiac failure in newborn infants with VGAM.
Materials and methods
Three infants with a diagnosis of VGAM and secondary severe cardiac failure were studied. These were consecutive admissions to the Neonatal Unit of the Royal Children's Hospital, Melbourne, between December 2005 and May 2006. Cases 1 and 2 presented in the first 48 h of life, with severe metabolic acidosis at presentation. Case 3 presented at 3 months of age. All three infants presented at other centres and were transferred to our institution by specialized transport teams.
Patient demographics, clinical presentation, initial management and MRI findings are provided in Table 1 .
The diagnosis of VGAM was made clinically and confirmed by cranial ultrasound and brain MRI. The latter was also used to assess the degree of brain injury at presentation.
Infants were ventilated and sedated to reduce metabolic demands. Vasodilating agents (milrinone) were used to reduce systemic vascular resistance (SVR), and improve systemic organ perfusion. Prostaglandin E 1 was used to maintain ductal patency in cases 1 and 2, with the intention of reducing afterload on the volume and pressure loaded right ventricle. In case 3 the ductus was closed.
In all three cases echocardiography was performed soon after admission and initial stabilization. A Philips Sonos 4500 (cases 1 and 2) and a Philips IE 33 (case 3) were used, both with 8 MHz probes (Philips Medical Systems, Bothell, WA, USA). Colour, pulsed-wave and continuous-wave Doppler were used to assess directions and velocities of blood flows. Pulmonary pressures were estimated from the maximum velocity of regurgitant tricuspid jet, using the modified Bernoulli's equation.
Pulsed-wave Doppler assessments of flow were acquired with a minimal angle (<151) of insonation and averaged over five cardiac cycles. Right ventricular (RV) output, left ventricular (LV) output and superior vena caval (SVC) flow were measured using techniques previously described in newborn infants. 5, 6 Proximal descending aortic flow assessment was obtained from a suprasternal view, with the Doppler sample volume at the level of ductal insertion. Ductal flow was assessed high parasternal view. The diameter of each vessel was measured from minimum and maximum diameters measured over five cardiac cycles from two-dimensional images.
Results
Echocardiographic findings at presentation are summarized in Table 2 . Figure 1 demonstrates blood flows and cardiac anatomy in each of the three cases, as compares with a normal circulation.
Briefly, cases 1 and 2 had small patent foramen ovale and moderate sized arterial ducts maintained by prostaglandin infusion. Case 3 had a large sinus venosus atrial septal defect (ASD), associated with partial anomalous pulmonary venous drainage (right pulmonary vein draining to right atrium). This association with VGAM is previously reported.
7,8 SVC flows were not obtained for case 3 due to technical difficulties distinguishing inter-atrial and SVC flows. RV output was not measured in case 1. The pulmonary trunk, pulmonary valve, proximal aorta and branches, SVC and innominate vein were enlarged in all patients.
All hearts were dilated with markedly enlarged right heart chambers causing leftward displacement of the ventricular and atrial septae. There was mild tricuspid regurgitation of high velocity indicating suprasystemic pulmonary pressures. Flow across the atrial septum was right to left in cases 1 and 2, and bidirectional in case 3. Flow in the patent arterial ductus was exclusively right to left.
Retrograde diastolic flow was seen in the descending thoracic aorta even at its most distal point in the thorax. Abnormally high flows were observed in the SVC, ascending aorta and main pulmonary artery.
Discussion
In this case series, we have provided a comprehensive echocardiographic assessment of the haemodynamics in VGAM Abbreviations: ASD, atrial septal defect; PAP, peak pulmonary artery pressure; PFO, patent foramen ovale; PAPVD partial anomalous pulmonary drainage; SSP, systolic systemic blood pressure.
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presenting as cardiac failure in early infancy. Our findings quantify the volume of flows through the head and neck in VGAM. This is the first report of SVC flows in VGAM, and has demonstrated flows up to 10 times higher than normal values. 5 Ventricular outputs were also increased. In our cases RV output was 2 to 3 times higher than normal. In the presence of a large patent ductus (cases 1 and 2) the RV output was disproportionately greater than the LV output, as previously observed by Patton and Fouron. 9 In case 3, in which there was no ductal flow, RV output and LV output were equal and over two and a half times normal. Similarly, increased LV outputs were reported in two cases of VGAM by Vaksmann et al. 4 On the basis of the consideration of the aortic and SVC flows in these cases it can be observed that over 80% of cardiac output passed through the AVM, resulting in a significant reduction to lower body perfusion, and severe lactic acidosis. Systemic perfusion was further reduced in diastole by 'steal' through the AVM that produced the characteristic reversed diastolic flow in the aorta, 10 which was present even in the low thoracic aorta in our cases.
Blood flow through the patent ductus arteriosus has not been previously quantified in VGAM. We have demonstrated that flow in the ductus (cases 1 and 2) represented up to 50% of right ventricular output, and was exclusively right to left indicating suprasystemic pulmonary pressures.
Suprasystemic pulmonary hypertension, present in all our cases, is a recognized feature of VGAM, and may be an independent predictor of poor prognosis. 11 Since pressure is a function of flow, this pulmonary hypertension has previously been attributed to increased blood flow through the pulmonary arteries. 12 Our study demonstrates the complex pathophysiology of cardiac failure in VGAM. The ventricles receive an increased preload, which Figure 1 Blood flows in normal heart and three cases of VGAM. All flows in ml/kg/min (IVC, Inferior vena cava; SVC, Superior vena cava; RA, right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle; RPA, right pulmonary artery; LPA, left pulmonary artery; Ao, aorta). Note: In VGAM circulation high SVC flows and ventricular outputs, dilated right ventricle and leftward displacement of interventricular septum. Large right-to-left flow through patent ductus (cases 1 and 2), which predominantly passes retrogradely up the aorta. they must attempt to eject. The right ventricle must do so against increased afterload (elevated pulmonary pressures), and becomes dilated, with resultant impaired diastolic filling and systolic contraction. The interventricular septum is displaced to the left and its normal motion compromised, which in turn impairs LV function (demonstrating ventricular interdependence). Myocardial metabolic demands are duly increased; however coronary artery flow is reduced due to diastolic steal to the AVM and shortened diastolic periods secondary to tachycardia. This results in myocardial ischaemia 3 and heart failure. The data presented here provide a rational basis for specific cardiovascular therapies aimed at reducing SVR and pulmonary vascular resistance (PVR) and improving myocardial function of the failing heart. Reducing SVR, by use of vasodilators, such as milrinone, promotes anterograde flow to the periphery and may reduce the relative steal through the AVM. Milrinone, a phosphodiesterase inhibitor, is particularly suited for use in VGAM because as well as its positive inotropic and systemic vasodilating properties, it is a cerebral vasodilator with the added potential benefit of improving brain tissue perfusion. 13, 14 Conversely, vasoconstricting chronotropic agents are contra-indicated because they will raise SVR, reduce systemic and cerebral perfusion and worsen myocardial ischaemia. 3 Pulmonary vasodilators (e.g., inhaled nitric oxide) will reduce PVR and therefore reduce afterload on the failing RV. There is a theoretical risk that pulmonary blood flow will increase sufficiently to impair lung function; however, we have not observed pulmonary oedema or worsening gas exchange in any patient treated with inhaled nitric oxide for this purpose.
The use of prostaglandin to maintain ductal patency offers two potential benefits to the failing circulation in VGAM. 15 First, rightto-left flow through a patent ductus has been proposed to allow flow to join the descending aorta and 'bypass' the AVM, although our data demonstrate that the majority of the right-to-left ductal flow actually passed retrogradely up the aorta toward the AVM. Second, the patent ductus may provide a 'blow-off' valve to the failing, pressure-loaded RV, preventing further RV dilatation and dysfunction. Prostaglandin has also been successfully used for this purpose in infants with severe pulmonary hypertension associated with congenital diaphragmatic hernia. 16 
Conclusion
Vein of Galen may present in early infancy with severe cardiac failure, which can progress to multiple organ failure and death. Using Doppler echocardiography, we have demonstrated the complex haemodynamics of this condition in the presence and absence of a patent arterial duct. These data provide a rationale for the use of systemic and pulmonary vasodilating therapies.
